Parkinson’s disease is the second most common neurodegenerative disease after dementia.
2017 marks the 200th anniversary since the 1817 publication of Dr James Parkinson’s seminal work on what he called the "Shaking Palsy".
The festive season is an intense time of year. Neuroscience can shed some light on what it does to our brains.
Spine-tingling or simply scary?
Are you impulsive and easily bored? You may be a thrill seeker.
Smoking therapy – not recommended.
Smoking causes 96,000 premature deaths a year in the UK. The fact that it protects against Parkinson's disease is not a reason to take up the habit.
Volunteering boosts your health.
Scientists have found that there are many physical and mental benefits to volunteering.
Using medicines to stay awake?
College students who take stimulants such as Adderall to get an academic edge might be setting themselves up unknowingly to a vicious cycle of substance abuse and addiction.
Damn you, dopamine.
Dopamine: a powerful substance that is much more than just a pleasure chemical.
When kids ask questions it can flick the switch on their curiosity and creativity.
Children's insatiable curiosity and search for new knowledge is getting lost somewhere along the way. We've mislaid the art of the question.
Food can prompt behaviours and brain responses similar to those seen in more traditional forms of addiction.
Are you a "carb craver" or "chocaholic"? We often use language associated with addiction to describe our relationships with food. But is it really possible to be addicted to certain types of food?
Video games have some clever ways of motivating players, and these methods can be used to get kids interested in learning.
There may be a chemical secret to getting kids interested in learning – and it's one that's created and produced by our own bodies rather than in a lab.
Excess dopamine activity is not the only neurological change seen in patients with schizophrenia.
Image from shutterstock.com
The landscape of pharmaceutical development for mental disorders has changed over recent years, with pharma companies abandoning traditional neuroscience drug discovery programs and turning instead to…